Roy Bakay to Nerve Growth Factor
This is a "connection" page, showing publications Roy Bakay has written about Nerve Growth Factor.
Connection Strength
0.172
-
A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease. Alzheimers Dement. 2014 Sep; 10(5):571-81.
Score: 0.111
-
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med. 2005 May; 11(5):551-5.
Score: 0.061